JCI - Citations to DC-based cancer vaccines

Citations to this article

DC-based cancer vaccines

Published May 1, 2007
Citation Information: J Clin Invest. 2007;117(5):1195-1203. https://doi.org/10.1172/JCI31205.

View: Text | PDF

Total citations by year

Year:	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	Total
Citations:	8	11	5	5	8	8	16	11	4	12	17	20	20	23	28	28	18	3	245

Citation information

Citations to this article (245)

Title and authors	Publication	Year
Neoantigen-targeted dendritic cell vaccine generates long-lived T cell responses exhibiting the full spectrum of differentiation states in lung cancer patients Joline Ingels, Laurenz Cock, Dieter Stevens, Rupert Mayer, Fabien Théry, Guillem S. Sanchez, David Vermijlen, Karin Weening, Saskia De Smet, Nele Lootens, Marieke Brusseel, Tasja Verstraete, Jolien Buyle, Eva Van Houtte, Pam Devreker, Kelly Heyns, Stijn Munter, Sandra Lint, Glenn Goetgeluk, Sarah Bonte, Lore Billiet, Melissa Pille, Hanne Jansen, Eva Pascal, Lucas Deseins, Lies Vantomme, Maarten Verdonckt, Ria Roelandt, Thomas Eekhout, Niels Vandamme, Georges Leclercq, Tom Taghon, Tessa Kerre, Floris Vanommeslaeghe, Annemieke Dhondt, Liesbeth Ferdinande, Jo Van Dorpe, Liesbeth Desender, Frederic De Ryck, Frank Vermassen, Veerle Surmont, Francis Impens, Björn Menten, Karim Vermaelen, Bart Vandekerckhove	Cell reports. Medicine	2024
ORC6 acts as an effective prognostic predictor for non‑small cell lung cancer and is closely associated with tumor progression Chen L, Zhang D, Chen Y, Zhu H, Liu Z, Yu Z, Xie J	Oncology Letters	2024
Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy Katopodi T, Petanidis S, Grigoriadou E, Anestakis D, Charalampidis C, Chatziprodromidou I, Floros G, Eskitzis P, Zarogoulidis P, Koulouris C, Sevva C, Papadopoulos K, Roulia P, Mantalovas S, Dagher M, Karakousis AV, Varsamis N, Vlassopoulos K, Theodorou V, Mystakidou CM, Katsios NI, Farmakis K, Kosmidis C	Pharmaceutics	2024
Advances in therapeutic cancer vaccines: Harnessing immune adjuvants for enhanced efficacy and future perspectives. Ren D, Xiong S, Ren Y, Yang X, Zhao X, Jin J, Xu M, Liang T, Guo L, Weng L	Computational and Structural Biotechnology Journal	2024
Bibliometric analysis of dendritic cell-based vaccines over the past 15 years. Long Z, Wu Y, Zhong L, Lu J, Liu B	Human vaccines & immunotherapeutics	2024
In vitro induction of anti‑lung cancer immune response by the A549 lung cancer stem cell lysate‑sensitized dendritic cell vaccine Chen L, Rao W, Chen Y, Xie J	Oncology Letters	2024
IGF1R inhibition and PD-1 blockade improve anti-tumor immune response in epithelial ovarian cancer. Somri-Gannam L, Meisel-Sharon S, Hantisteanu S, Bar-Noy T, Sigal E, Groisman G, Hallak M, Werner H, Bruchim I	Frontiers in oncology	2024
Lipid Nanoparticle‐mRNA Engineered Dendritic Cell Based Adoptive Cell Therapy Enhances Cancer Immune Response Das R, Ge X, Fei F, Parvanian S, Weissleder R, Garris CS	Small Methods	2024
A recombinant rabies virus chimera expressing the DC-targeting molecular MAB2560 shows enhanced vaccine immunogenicity through activation of dendritic cells Gong Z, Huang P, Jin H, Bai Y, Li H, Qian M, Sun J, Jiao C, Zhang M, Li Y, Zhang H, Wang H	PLoS neglected tropical diseases	2023
Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities. Wang MM, Coupland SE, Aittokallio T, Figueiredo CR	British Journal of Cancer	2023
Modular Hydrogel Vaccine for Programmable and Coordinate Elicitation of Cancer Immunotherapy Ji P, Sun W, Zhang S, Xing Y, Wang C, Wei M, Li Q, Ji G, Yang G	Advanced Science	2023
An iPSC-derived exosome-pulsed dendritic cell vaccine boosts antitumor immunity in melanoma Wang R, Zhu T, Hou B, Huang X	Molecular Therapy	2023
Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations. Lee KW, Yam JWP, Mao X	Cells	2023
Current advances in cancer vaccines targeting NY-ESO-1 for solid cancer treatment Zhou H, Ma Y, Liu F, Li B, Qiao D, Ren P, Wang M	Frontiers in immunology	2023
Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer Rocca C, Soda T, De Francesco EM, Fiorillo M, Moccia F, Viglietto G, Angelone T, Amodio N	Journal of Translational Medicine	2023
Knowledge mapping of therapeutic cancer vaccine from 2013 to 2022: A bibliometric and visual analysis Zhao J, Liao B, Gong L, Yang H, Li S, Li Y	Human Vaccines & Immunotherapeutics	2023
Laponite Lights Calcium Flickers by Reprogramming Lysosomes to Steer DC Migration for An Effective Antiviral CD8+ T‐Cell Response Li C, Hou Y, He M, Lv L, Zhang Y, Sun S, Zhao Y, Liu X, Ma P, Wang X, Zhou Q, Zhan L	Advanced Science	2023
An injectable signal-amplifying device elicits a specific immune response against malignant glioblastoma Qiu Q, Chen S, He H, Chen J, Ding X, Wang D, Yang J, Guo P, Li Y, Kim J, Sheng J, Gao C, Yin B, Zheng S, Wang J	Acta pharmaceutica Sinica. B	2023
Incorporation of Escherichia coli heat-labile enterotoxin B subunit into rabies virus particles enhances its immunogenicity in mice and dogs Gong Z, Li H, Qian M, Bai Y, Jin H, Sun J, Zhang M, Jiao C, Huang P, Li Y, Zhang H, Wang H	Biosafety and Health	2023
Biomedical polymers: synthesis, properties, and applications W Chen, Q Chen, Q Chen, C Cui, S Duan, Y Kang, Y Liu, Y Liu, W Muhammad, S Shao, C Tang, J Wang, L Wang, M Xiong, L Yin, K Zhang, Z Zhang, X Zhen, J Feng, C Gao, Z Gu, C He, J Ji, X Jiang, W Liu, Z Liu, H Peng, Y Shen, L Shi, X Sun, H Wang, J Wang, H Xiao, F Xu, Z Zhong, X Zhang, X Chen	Science China Chemistry	2022
Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model. Barshidi A, Karpisheh V, Noukabadi FK, Kiani FK, Mohammadi M, Afsharimanesh N, Ebrahimi F, Kiaie SH, Navashenaq JG, Hojjat-Farsangi M, Zolbanin NM, Mahmoodpoor A, Hassannia H, Nami S, Jalali P, Jafari R, Jadidi-Niaragh F	Pharmaceutical Research	2022
Tolerogenic Dendritic Cells Induce Apoptosis-Independent T Cell Hyporesponsiveness of SARS-CoV-2-Specific T Cells in an Antigen-Specific Manner Van Delen M, Janssens I, Dams A, Roosens L, Ogunjimi B, Berneman ZN, Derdelinckx J, Cools N	International journal of molecular sciences	2022
The mononuclear phagocyte system in hepatocellular carcinoma Qiao DR, Shan GY, Wang S, Cheng JY, Yan WQ, Li HJ	World Journal of Gastroenterology	2022
Immunomodulatory role of metalloproteases in cancers: Current progress and future trends Wang Q, Wang K, Tan X, Li Z, Wang H	Frontiers in immunology	2022
Extracellular Vesicles as an Advanced Delivery Biomaterial for Precision Cancer Immunotherapy S Ruan, Z Greenberg, X Pan, P Zhuang, N Erwin, M He	Advanced Healthcare Materials	2021
Recombinant Pseudorabies Virus with TK/gE Gene Deletion and Flt3L Co-Expression Enhances the Innate and Adaptive Immune Response via Activating Dendritic Cells L Yao, Q Hu, S Chen, T Zhou, X Yu, H Ma, AH Ghonaim, H Wu, Q Sun, S Fan, Q He	Viruses	2021
Cancer Vaccines for Genitourinary Tumors: Recent Progresses and Future Possibilities BA Maiorano, G Schinzari, D Ciardiello, MG Rodriquenz, A Cisternino, G Tortora, E Maiello	Human vaccines	2021
A brief review on DNA vaccines in the era of COVID-19 Shafaati M, Saidijam M, Soleimani M, Hazrati F, Mirzaei R, Amirheidari B, Tanzadehpanah H, Karampoor S, Kazemi S, Yavari B, Mahaki H, Safaei M, Rahbarizadeh F, Samadi P, Ahmadyousefi Y	Future Virology	2021
Therapeutic Antitumor Efficacy of Cancer Stem Cell-Derived DRibble Vaccine on Colorectal Carcinoma Fu C, Tian G, Duan J, Liu K, Zhang C, Yan W, Wang Y	International journal of medical sciences	2021
A Novel Model of Cancer Drug Resistance: Oncosomal Release of Cytotoxic and Antibody-Based Drugs T Eguchi, EA Taha, SK Calderwood, K Ono	Biology : open access journal	2020
Dendritic Cells, the T-cell-inflamed Tumor Microenvironment, and Immunotherapy Treatment Response CS Garris, JJ Luke	Clinical cancer research	2020
Cancer stem cells and strategies for targeted drug delivery J Cao, S Bhatnagar, J Wang, X Qi, S Prabha, J Panyam	Drug Delivery and Translational Research	2020
Engineered biomaterials for cancer immunotherapy L Cai, J Xu, Z Yang, R Tong, Z Dong, C Wang, KW Leong		2020
Engineered Nanodelivery Systems to Improve DNA Vaccine Technologies M Lim, A ZayedBadruddoza, J Firdous, M Azad, A Mannan, TA Al-Hilal, CS Cho, MA Islam	Pharmaceutics	2020
Improvement of DC-based vaccines using adjuvant TLR4-binding 60S acidic ribosomal protein P2 and immune checkpoint inhibitors GY Jang, YS Kim, SE Lee, J won Lee, HD Han, TH Kang, YM Park	Cancer Immunology, Immunotherapy	2020
Nanotherapeutics for Immuno-Oncology: A Crossroad for New Paradigms W Song, M Das, X Chen	Trends in Cancer	2020
Extracorporeal Photopheresis: A Case of Immunotherapy Ahead of Its Time PA Vieyra-Garcia, P Wolf	Transfusion Medicine and Hemotherapy	2020
Harnessing Dendritic Cells for Poly (D,L-lactide-co-glycolide) Microspheres (PLGA MS)—Mediated Anti-tumor Therapy J Koerner, D Horvath, M Groettrup	Frontiers in immunology	2019
Honokiol-enhanced cytotoxic T lymphocyte activity against cholangiocarcinoma cells mediated by dendritic cells pulsed with damage-associated molecular patterns A Jiraviriyakul, W Songjang, P Kaewthet, P Tanawatkitichai, P Bayan, S Pongcharoen	World journal of gastroenterology : WJG	2019
Biomaterial-based platforms for in situ dendritic cell programming and their use in antitumor immunotherapy J Calmeiro, M Carrascal, C Gomes, A Falcão, MT Cruz, BM Neves	Journal for ImmunoTherapy of Cancer	2019
Editorial: Combinatorial Approaches to Enhance Anti-tumor Immunity: Focus on Immune Checkpoint Blockade Therapy P Andersson, C Ostheimer	Frontiers in immunology	2019
Trial watch: dendritic cell vaccination for cancer immunotherapy J Sprooten, J Ceusters, A Coosemans, P Agostinis, SD Vleeschouwer, L Zitvogel, G Kroemer, L Galluzzi, AD Garg	OncoImmunology	2019
Cytolytic Activity of Effector T-lymphocytes Against Hepatocellular Carcinoma is Improved by Dendritic Cells Pulsed with Pooled Tumor Antigens T Chieochansin, C Thepmalee, J Grainok, M Junking, P Yenchitsomanus	Scientific Reports	2019
A Recombinant Rabies Virus Expressing Fms-like Tyrosine Kinase 3 Ligand (Flt3L) Induces Enhanced Immunogenicity in Mice Y Zhang, J Yang, M Li, M Cui, ZF Fu, L Zhao, M Zhou	Virologica Sinica	2019
Dendritic cells loaded with CD44+ CT‑26 colon cell lysate evoke potent antitumor immune responses C Fu, N Zhou, Y Zhao, J Duan, H Xu, Y Wang	Oncology Letters	2019
Efficacy of Intracellular Immune Checkpoint-Silenced Dendritic Cell Vaccine Danhong Wang, Xue F Huang, Bangxing Hong, Xiao-Tong Song, Liangding Hu, Min Jiang, Bin Zhang, Hongmei Ning, Yuhang Li, Chen Xu, Xiao Lou, Botao Li, Zhiyong Yu, Jiangwei Hu, Jianlin Chen, Fan Yang, Haiyan Gao, Guoliang Ding, Lianming Liao, Lisa Rollins, Lindsey Jones, Si-Yi Chen, Hu Chen	JCI Insight	2018
Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer DC Lazăr, MF Avram, I Romoșan, M Cornianu, S Tăban, A Goldiș	World journal of gastroenterology : WJG	2018
EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells YJ Choi, SJ Park, YS Park, HS Park, KM Yang, K Heo, D Nie	PloS one	2018
The Role of the Insulin-Like Growth Factor 1 Pathway in Immune Tumor Microenvironment and Its Clinical Ramifications in Gynecologic Malignancies MA Yahya, SM Sharon, S Hantisteanu, M Hallak, I Bruchim	Frontiers in Endocrinology	2018
TNP-470 skews DC differentiation to Th1-stimulatory phenotypes and can serve as a novel adjuvant in a cancer vaccine DH Ho, RH Wong	Blood Advances	2018
What’s New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives G Tirino, L Pompella, A Petrillo, M Laterza, A Pappalardo, M Caterino, M Orditura, F Ciardiello, G Galizia, FD Vita	International journal of molecular sciences	2018
Precision-porous templated scaffolds of varying pore size drive dendritic cell activation R Chen, H Ma, L Zhang, JD Bryers	Biotechnology and Bioengineering	2018
Modulation of the Tumor Microenvironment by CXCR4 Antagonist-Armed Viral Oncotherapy Enhances the Antitumor Efficacy of Dendritic Cell Vaccines against Neuroblastoma in Syngeneic Mice M Komorowski, J Tisonczyk, A Kolakowska, R Drozdz, D Kozbor	Viruses	2018
Impact of 5-Fu/oxaliplatin on mouse dendritic cells and synergetic effect with a colon cancer vaccine X Hong, T Dong, T Yi, J Hu, Z Zhang, S Lin, W Niu	Chinese Journal of Cancer Research	2018
Injectable Biodegradable Chitosan-Alginate 3D Porous Gel Scaffold for mRNA Vaccine Delivery J Yan, R Chen, H Zhang, JD Bryers	Macromolecular Bioscience	2018
Single-Cell Transcriptomics in Cancer Immunobiology: The Future of Precision Oncology F Valdes-Mora, K Handler, AM Law, R Salomon, SR Oakes, CJ Ormandy, D Gallego-Ortega	Frontiers in immunology	2018
Dendritic cell-based vaccination: powerful resources of immature dendritic cells against pancreatic adenocarcinoma Aurélie Collignon, Françoise Silvy, Stéphane Robert, Malika Trad, Sébastien Germain, Jérémy Nigri, Frédéric André, Véronique Rigot, Richard Tomasini, Bernard Bonnotte, Dominique Lombardo, Eric Mas, Evelyne Beraud	OncoImmunology	2018
Exosomes derived from rAAV/AFP-transfected dendritic cells elicit specific T cell-mediated immune responses against hepatocellular carcinoma J Li, S Huang, Z Zhou, W Lin, S Chen, M Chen, Y Ye	Cancer management and research	2018
Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes N Santana-Magal, D Rasoulouniriana, C Saperia, A Gutwillig, P Rider, EG Engleman, Y Carmi	Journal of visualized experiments : JoVE	2018
Dendritic cell vaccine with Ag85A enhances anti‑colorectal carcinoma immunity J Zhai, W Gao, L Zhao, Z Gao, X Jiang, C Lu	Experimental and therapeutic medicine	2018
Optimization of Dendritic Cell-Mediated Cytotoxic T-Cell Activation by Tracking of Dendritic Cell Migration Using Reporter Gene Imaging. Lee H, Lee HW, La Lee Y, Jeon YH, Jeong SY, Lee SW, Lee J, Ahn BC	Molecular Imaging and Biology	2018
12-year survival and immune correlates in Dendritic Cell-vaccinated melanoma patients Stefanie Gross, Michael Erdmann, Ina Haendle, Steve Voland, Thomas Berger, Erwin Schultz, Erwin Strasser, Peter Dankerl, Rolf Janka, Stefan Schliep, Lucie Heinzerling, Karl SOTLAR, Pierre Coulie, Gerold Schuler, Beatrice Schuler-Thurner	JCI Insight	2017
Tumor-derived exosomes educate dendritic cells to promote tumor metastasis via HSP72/HSP105-TLR2/TLR4 pathway Y Shen, D Guo, L Weng, S Wang, Z Ma, Y Yang, P Wang, J Wang, Z Cai	OncoImmunology	2017
Generation of potent cytotoxic T lymphocytes against in male patients with non-muscle invasive bladder cancer by dendritic cells loaded with dying T24 bladder cancer cells EC Hwang, SI Jung, HJ Lee, JJ Lee, DD Kwon	International braz j urol	2017
Functional ferritin nanoparticles for biomedical applications Z Wang, H Gao, Y Zhang, G Liu, G Niu, X Chen	Frontiers of Chemical Science and Engineering	2017
Trial Watch: Dendritic cell-based anticancer immunotherapy AD Garg, MV Perez, M Schaaf, P Agostinis, L Zitvogel, G Kroemer, L Galluzzi	OncoImmunology	2017
Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists T Lövgren, D Sarhan, I Truxová, B Choudhary, R Maas, J Melief, M Nyström, U Edbäck, R Vermeij, G Scurti, M Nishimura, G Masucci, A Karlsson-Parra, A Lundqvist, L Adamson, R Kiessling	Cancer Immunology, Immunotherapy	2017
Inherent Immunogenicity or Lack Thereof of Pluripotent Stem Cells: Implications for Cell Replacement Therapy A Chhabra	Frontiers in immunology	2017
Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen–specific CTLs MC Brown, EK Holl, D Boczkowski, E Dobrikova, M Mosaheb, V Chandramohan, DD Bigner, M Gromeier, SK Nair	Science Translational Medicine	2017
Defining a standard and weighted mathematical index for maturation of dendritic cells A Landi, MT Aligodarzi, A Khodadadi, LA Babiuk, S van Drunen Littel-van den Hurk	Immunology	2017
Recombinant rabies virus with the glycoprotein fused with a DC-binding peptide is an efficacious rabies vaccine Y Zhang, M Zhou, Y Li, Z Luo, H Chen, M Cui, ZF Fu, L Zhao	Oncotarget	2017
Tumor Immuno-Environment in Cancer Progression and Therapy. Kalinski P, Talmadge JE	Advances in experimental medicine and biology	2017
Inhibition of SIRPα in dendritic cells potentiates potent antitumor immunity Q Liu, W Wen, L Tang, CJ Qin, Y Lin, HL Zhang, H Wu, C Ashton, HP Wu, J Ding, W Dong, LX Yu, W Yang, DD Huang, MC Wu, HY Wang, HX Yan	OncoImmunology	2016
Immune Cells in Cancer Therapy and Drug Delivery C Eyileten, K Majchrzak, Z Pilch, K Tonecka, J Mucha, B Taciak, K Ulewicz, K Witt, A Boffi, M Krol, TP Rygiel	Mediators of Inflammation	2016
Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response YT Lim, C Song, YW Noh	International Journal of Nanomedicine	2016
Immunological Characterization of Whole Tumour Lysate-Loaded Dendritic Cells for Cancer Immunotherapy V Rainone, C Martelli, L Ottobrini, M Biasin, M Borelli, G Lucignani, D Trabattoni, M Clerici, N Lapteva	PloS one	2016
Optimizing the process of nucleofection for professional antigen presenting cells CS Mullins, T Wegner, E Klar, CF Classen, M Linnebacher	BMC Research Notes	2015
Adenosine 2A receptors in acute kidney injury IS Vincent, MD Okusa	Acta physiologica (Oxford, England)	2015
Progression of Large Lymphoma Is Significantly Impeded with a Combination of Gemcitabine Chemotherapy and Dendritic Cells Intra-Tumor Vaccination XJ Zhu, ZF Yang, JY Zhou, L Liu, XM Sun, ZF Fan, SY Hu, YC Chen, WX Li, M Cao, LX Wang, H Shiku	PloS one	2015
The siRNA cocktail targeting interleukin 10 receptor and transforming growth factor-β receptor on dendritic cells potentiates tumour antigen-specific CD8 + T cell immunity: Adjuvant siRNA cocktail for DC-based vaccine YH Ahn, SO Hong, JH Kim, KH Noh, KH Song, YH Lee, JH Jeon, DW Kim, JH Seo, TW Kim	Clinical & Experimental Immunology	2015
Gastric cancer and the epoch of immunotherapy approaches Elena Niccolai, Antonio Taddei, Antonio Taddei, Domenico Prisco, Domenico Prisco, Amedeo Amedei, Amedeo Amedei	World Journal of Gastroenterology	2015
Advances in Experimental Medicine and Biology JL Platt, LE Wrenshall, GB Johnson, M Cascalho	Advances in experimental medicine and biology	2015
Study on the mesothelin-specific cytotoxicity against epithelial ovarian cancer with full-length mesothelin cDNA-transduced dendritic cells D Wang, X Wu, S Qian, HR Yao	Medical Oncology	2015
Can dendritic cells improve whole cancer cell vaccines based on immunogenically killed cancer cells? L Cicchelero, S Denies, B Devriendt, H Rooster, NN Sanders	OncoImmunology	2015
Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy VV Subhash, MS Yeo, WL Tan, WP Yong	Journal of Immunology Research	2015
Safe and Reproducible Preparation of Functional Dendritic Cells for Immunotherapy in Glioblastoma Patients S Nava, D Lisini, S Pogliani, M Dossena, A Bersano, S Pellegatta, E Parati, G Finocchiaro, S Frigerio	Stem Cells Translational Medicine	2015
Antigenically Modified Human Pluripotent Stem Cells Generate Antigen-Presenting Dendritic Cells J Zeng, C Wu, S Wang	Scientific Reports	2015
Genetic Immunization With In Vivo Dendritic Cell-targeting Liposomal DNA Vaccine Carrier Induces Long-lasting Antitumor Immune Response A Garu, G Moku, SK Gulla, A Chaudhuri	Molecular Therapy	2015
Identification of Immune Factors Regulating Antitumor Immunity Using Polymeric Vaccines with Multiple Adjuvants OA Ali, C Verbeke, C Johnson, RW Sands, SA Lewin, D White, E Doherty, G Dranoff, DJ Mooney	Cancer research	2014
Immunotherapy advances for glioblastoma DA Reardon, G Freeman, C Wu, EA Chiocca, KW Wucherpfennig, PY Wen, EF Fritsch, WT Curry, JH Sampson, G Dranoff	Neuro-Oncology	2014
Size-dependent effects of gold nanoparticles uptake on maturation and antitumor functions of human dendritic cells in vitro S Tomić, J Dokić, S Vasilijić, N Ogrinc, R Rudolf, P Pelicon, D Vučević, P Milosavljević, S Janković, I Anžel, J Rajković, MS Rupnik, B Friedrich, M Colić	PloS one	2014
A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs KJ Kallen, A Theß	Therapeutic advances in vaccines	2014
A Potential Protein Adjuvant Derived from Mycobacterium tuberculosis Rv0652 Enhances Dendritic Cells-Based Tumor Immunotherapy SJ Lee, SJ Shin, MH Lee, MG Lee, TH Kang, WS Park, BY Soh, JH Park, YK Shin, HW Kim, CH Yun, ID Jung, YM Park	PloS one	2014
Natural killer T cells play a necessary role in modulating of immune-mediated liver injury by gut microbiota J Chen, Y Wei, J He, G Cui, Y Zhu, C Lu, Y Ding, R Xue, L Bai, T Uede, L Li, H Diao	Scientific Reports	2014
Dendritic cell immunotherapy in uterine cancer A Coosemans, S Tuyaerts, A Vanderstraeten, I Vergote, F Amant, SW van Gool	Human Vaccines & Immunotherapeutics	2014
Human IP10-scFv and DC-induced CTL synergistically inhibit the growth of glioma in a xenograft model X Wang, FC Zhang, HY Zhao, XL Lu, Y Sun, ZY Xiong, XB Jiang	Tumor Biology	2014
Laser vaccine adjuvants: History, progress, and potential S Kashiwagi, T Brauns, J Gelfand, MC Poznansky	Human Vaccines & Immunotherapeutics	2014
In Situ Modulation of Dendritic Cells by Injectable Thermosensitive Hydrogels for Cancer Vaccines in Mice Y Liu, L Xiao, KI Joo, B Hu, J Fang, P Wang	Biomacromolecules	2014
Trial watch: Dendritic cell-based anticancer therapy N Bloy, J Pol, F Aranda, A Eggermont, I Cremer, WH Fridman, J Fučíková, J Galon, E Tartour, R Spisek, MV Dhodapkar, L Zitvogel, G Kroemer, L Galluzzi	OncoImmunology	2014
Recent advances in the use of therapeutic cancer vaccines in genitourinary malignancies I Surolia, J Gulley, RA Madan	Expert Opinion on Biological Therapy	2014
Exploitation of Langerhans cells for in vivo DNA vaccine delivery into the lymph nodes ER Tőke, O Lőrincz, Z Csiszovszki, E Somogyi, G Felföldi, L Molnár, R Szipőcs, A Kolonics, B Malissen, F Lori, J Trocio, N Bakare, F Horkay, N Romani, CH Tripp, P Stoitzner, J Lisziewicz	Gene Therapy	2014
Regulatory dendritic cell therapy: From rodents to clinical application D Raïch-Regué, M Glancy, AW Thomson	Immunology Letters	2014
Pre-immature dendritic cells (PIDC) pulsed with HPV16 E6 or E7 peptide are capable of eliciting specific immune response in patients with advanced cervical cancer OE Rahma, VE Herrin, RA Ibrahim, A Toubaji, S Bernstein, O Dakheel, SM Steinberg, RA Eid, M Mkrtichyan, JA Berzofsky, SN Khleif	Journal of Translational Medicine	2014
Human dendritic cell activation induced by a permannosylated dendron containing an antigenic GM 3 -lactone mimetic R Ribeiro-Viana, E Bonechi, J Rojo, C Ballerini, G Comito, B Richichi, C Nativi	Beilstein Journal of Organic Chemistry	2014
Classification of current anticancer immunotherapies Galluzzi L, Vacchelli E, Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, Bracci L, Caignard A, Castelli C, Cavallo F, Celis E, Cerundolo V, Clayton A, Colombo MP, Coussens L, Dhodapkar MV, Eggermont AM, Fearon DT, Fridman WH, Fučíková J, Gabrilovich DI, Galon J, Garg A, Ghiringhelli F, Giaccone G, Gilboa E, Gnjatic S, Hoos A, Hosmalin A, Jäger D, Kalinski P, Kärre K, Kepp O, Kiessling R, Kirkwood JM, Klein E, Knuth A, Lewis CE, Liblau R, Lotze MT, Lugli E, Mach JP, Mattei F, Mavilio D, Melero I, Melief CJ, Mittendorf EA, Moretta L, Odunsi A, Okada H, Palucka AK, Peter ME, Pienta KJ, Porgador A, Prendergast GC, Rabinovich GA, Restifo NP, Rizvi N, Sautès-Fridman C, Schreiber H, Seliger B, Shiku H, Silva-Santos B, Smyth MJ, Speiser DE, Spisek R, Srivastava PK, Talmadge JE, Tartour E, Van Der Burg SH, Van Den Eynde BJ, Vile R, Wagner H, Weber JS, Whiteside TL, Wolchok JD, Zitvogel L, Zou W, Kroemer G	Oncotarget	2014
Relationship of vaccine efficacy to the kinetics of DC and T-cell responses induced by PLG-based cancer vaccines OA Ali, E Doherty, DJ Mooney, D Emerich	Biomatter	2013
Rhamnogalacturonan II is a Toll-like receptor 4 agonist that inhibits tumor growth by activating dendritic cell-mediated CD8+ T cells SN Park, KT Noh, YI Jeong, ID Jung, HK Kang, GS Cha, SJ Lee, JK Seo, DH Kang, TH Hwang, EK Lee, B Kwon, YM Park	Experimental & molecular medicine	2013
CpG oligodeoxynucleotide as immune adjuvant enhances photodynamic therapy response in murine metastatic breast cancer Y Xia, GK Gupta, AP Castano, P Mroz, P Avci, MR Hamblin	Journal of Biophotonics	2013
Inflammatory Cytokines Presented from Polymer Matrices Differentially Generate and Activate DCs In Situ OA Ali, P Tayalia, D Shvartsman, S Lewin, DJ Mooney	Advanced Functional Materials	2013
Natural killer T cells in advanced melanoma patients treated with tremelimumab FJ Ibarrondo, OO Yang, T Chodon, E Avramis, Y Lee, H Sazegar, J Jalil, B Chmielowski, RC Koya, I Schmid, J Gomez-Navarro, BD Jamieson, A Ribas, B Comin-Anduix	PloS one	2013
Immune-maximizing (IMAX) therapy for cancer: Combination of dendritic cell vaccine and intensity-modulated radiation Y Shibamoto, M Okamoto, M Kobayashi, S Ayakawa, H Iwata, C Sugie, Y Mitsuishi, H Takahashi	Molecular and Clinical Oncology	2013
Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go A Vasaturo, SD Blasio, DG Peeters, CC de Koning, JM de Vries, CG Figdor, SV Hato	Frontiers in immunology	2013
A novel and simple method for generation of human dendritic cells from unfractionated peripheral blood mononuclear cells within 2 days: its application for induction of HIV-1-reactive CD4(+) T cells in the hu-PBL SCID mice A Kodama, R Tanaka, M Saito, AA Ansari, Y Tanaka	Frontiers in microbiology	2013
A suppressor of cytokine signaling 1 antagonist enhances antigen-presenting capacity and tumor cell antigen-specific cytotoxic T lymphocyte responses by human monocyte-derived dendritic cells Y Wang, S Wang, Y Ding, Y Ye, Y Xu, H He, Q Li, Y Mi, C Guo, Z Lin, T Liu, Y Zhang, Y Chen, J Yan	Clinical and vaccine immunology : CVI	2013
Bee Venom Phospholipase A2, a Good "Chauffeur" for Delivering Tumor Antigen to the MHC I and MHC II Peptide-Loading Compartments of the Dendritic Cells: The Case of NY-ESO-1 C Almunia, M Bretaudeau, G Held, A Babon, C Marchetti, FA Castelli, A Ménez, B Maillere, D Gillet	PloS one	2013
The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates S Pellegatta, M Eoli, S Frigerio, C Antozzi, MG Bruzzone, G Cantini, S Nava, E Anghileri, L Cuppini, V Cuccarini, E Ciusani, M Dossena, B Pollo, R Mantegazza, EA Parati, G Finocchiaro	OncoImmunology	2013
Cytotoxicity of tumor antigen specific human T cells is unimpaired by arginine depletion M Munder, M Engelhardt, D Knies, S Medenhoff, G Wabnitz, C Luckner-Minden, N Feldmeyer, RH Voss, P Kropf, I Müller, R Conradi, Y Samstag, M Theobald, AD Ho, H Goldschmidt, M Hundemer	PloS one	2013
Recombinant rabies viruses expressing GM-CSF or flagellin are effective vaccines for both intramuscular and oral immunizations M Zhou, G Zhang, G Ren, CW Gnanadurai, Z Li, Q Chai, Y Yang, CM Leyson, W Wu, M Cui, ZF Fu	PloS one	2013
Recombinant mammaglobin A adenovirus-infected dendritic cells induce mammaglobin A-specific CD8+ cytotoxic T lymphocytes against breast cancer cells in vitro H Cui, W Zhang, W Hu, K Liu, T Wang, N Ma, X Liu, Y Liu, Y Jiang	PloS one	2013
Trial watch E Vacchelli, I Vitale, A Eggermont, WH Fridman, J Fučíková, I Cremer, J Galon, E Tartour, L Zitvogel, G Kroemer, L Galluzzi	OncoImmunology	2013
Human Parainfluenza Virus Type 2 Vector Induces Dendritic Cell Maturation Without Viral RNA Replication/Transcription K Hara, M Fukumura, J Ohtsuka, M Kawano, T Nosaka	Human Gene Therapy	2013
Dendritic cell-based immunotherapy in ovarian cancer A Coosemans, I Vergote, SW van Gool	OncoImmunology	2013
CD8+ T-cell priming and boosting: more antigen-presenting DC, or more antigen per DC? N Schaft, V Wellner, C Wohn, G Schuler, J Dörrie	Cancer Immunology, Immunotherapy	2013
Activation of Dendritic Cells by the Novel Toll-Like Receptor 3 Agonist RGC100 K Naumann, R Wehner, A Schwarze, C Petzold, M Schmitz, J Rohayem	Clinical and Developmental Immunology	2013
Immune response, clinical outcome and safety of dendritic cell vaccine in combination with cytokine-induced killer cell therapy in cancer patients YU CUI, X Yang, W Zhu, J Li, X Wu, Y Pang	Oncology Letters	2013
Trial watch L Galluzzi, L Senovilla, E Vacchelli, A Eggermont, WH Fridman, J Galon, C Sautès-Fridman, E Tartour, L Zitvogel, G Kroemer	OncoImmunology	2012
Tumor-Associated Antigens for Specific Immunotherapy of Prostate Cancer A Kiessling, R Wehner, S Füssel, M Bachmann, MP Wirth, M Schmitz	Cancers	2012
PD-1/PD-L1 Blockade Can Enhance HIV-1 Gag-specific T Cell Immunity Elicited by Dendritic Cell-Directed Lentiviral Vaccines B Dai, L Xiao, PD Bryson, J Fang, P Wang	Molecular Therapy	2012
Dendritic Cells The Tumor Microenvironment and the Challenges for an Effective Antitumor Vaccination F Benencia, L Sprague, J McGinty, M Pate, M Muccioli	Journal of Biomedicine and Biotechnology	2012
Combined Tbet and IL12 Gene Therapy Elicits and Recruits Superior Antitumor Immunity In Vivo Y Qu, L Chen, DB Lowe, WJ Storkus, JL Taylor	Molecular Therapy	2012
Identification of novel HLA-A*0201-restricted epitopes from anterior gradient-2 as a tumor-associated antigen against colorectal cancer HJ Lee, CY Hong, CJ Jin, MH Kim, YK Lee, TN Nguyen-Pham, H Lee, BC Park, IJ Chung, HJ Kim, JJ Lee	Cellular and Molecular Immunology	2012
Off-the-shelf Adenoviral-mediated Immunotherapy via Bicistronic Expression of Tumor Antigen and iMyD88/CD40 Adjuvant JO Kemnade, M Seethammagari, P Narayanan, JM Levitt, AA McCormick, DM Spencer	Molecular Therapy	2012
HPK1 as a novel target for cancer immunotherapy S Sawasdikosol, R Zha, B Yang, S Burakoff	Immunologic Research	2012
Interleukin-12p70 Expression by Dendritic Cells of HIV-1-Infected Patients Fails to Stimulate gag-Specific Immune Responses EV Gulck, N Cools, D Atkinson, L Bracke, K Vereecken, M Vekemans, VF van Tendeloo, ZN Berneman, G Vanham	Clinical and Developmental Immunology	2012
Lactobacillus acidophilus Could Modulate the Immune Response Against Breast Cancer in Murine Model H Maroof, ZM Hassan, AM Mobarez, MA Mohamadabadi	Journal of Clinical Immunology	2012
Current Protocols in Immunology S Nair, GE Archer, TF Tedder	Current Protocols in Immunology	2012
Immunoregulatory properties of rapamycin-conditioned monocyte-derived dendritic cells and their role in transplantation C Macedo, H Turquist, D Metes, AW Thomson	Transplantation Research	2012
An optimized method for manufacturing a clinical scale dendritic cell-based vaccine for the treatment of glioblastoma S Nava, M Dossena, S Pogliani, S Pellegatta, C Antozzi, F Baggi, C Gellera, B Pollo, EA Parati, G Finocchiaro, S Frigerio	PloS one	2012
Expression of ESE-3 isoforms in immunogenic and tolerogenic human monocyte-derived dendritic cells F Sprater, AO Hovden, S Appel	PloS one	2012
Vaccines for Pancreatic Cancer KC Soares, L Zheng, B Edil, EM Jaffee	The Cancer Journal	2012
Methionine enkephalin (MENK) improved the functions of bone marrow-derived dendritic cells (BMDCs) loaded with antigen W Li, J Meng, X Li, H Hua, Y Meng, Q Wang, E Wang, F Shan	Human Vaccines & Immunotherapeutics	2012
In vivo imaging of lymph node migration of MNP- and (111)In-labeled dendritic cells in a transgenic mouse model of breast cancer (MMTV-Ras). Martelli C, Borelli M, Ottobrini L, Rainone V, Degrassi A, Russo M, Gianelli U, Bosari S, Fiorini C, Trabattoni D, Clerici M, Lucignani G	Molecular Imaging and Biology	2012
Synergistical toll-like receptors activated dendritic cells induce antitumor effects against carcinoembryonic antigen-expressing colon cancer. Hong X, Dong T, Hu J, Yi T, Li W, Zhang Z, Lin S, Niu W	International Journal of Colorectal Disease	2012
RAFTsomes containing epitope-MHC-II complexes mediated CD4+ T cell activation and antigen-specific immune responses. Ding Q, Chen J, Wei X, Sun W, Mai J, Yang Y, Xu Y	Pharmaceutical Research	2012
Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial Ellebaek E, Engell-Noerregaard L, Iversen TZ, Froesig TM, Munir S, Hadrup SR, Andersen MH, Svane IM	Cancer Immunology, Immunotherapy	2012
A composite MyD88/CD40 “switch” synergistically activates mouse and human dendritic cells for enhanced anti-tumor efficacy Priyadharshini Narayanan, Natalia Lapteva, Mamatha Seethammagari, Jonathan Levitt, Kevin Slawin, David Spencer	Journal of Clinical Investigation	2011
Viral tumor inflammation facilitates effective dendritic cell cancer immunotherapy in a regulatory T cell-dependent manner Norman Woller, Sarah Knocke, Bettina Mundt, Engin Gürlevik, Nina Strüver, Arnold Kloos, Bita Boozari, Peter Schache, Michael P. Manns, Nisar Malek, Tim Sparwasser, Lars Zender, Thomas Wirth, Stefan Kubicka, Florian Kühnel	Journal of Clinical Investigation	2011
Maturation of monocyte derived dendritic cells with OK432 boosts IL-12p70 secretion and conveys strong T-cell responses AO Hovden, M Karlsen, R Jonsson, HJ Aarstad, S Appel	BMC Immunology	2011
A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients OE Rahma, E Ashtar, M Czystowska, ME Szajnik, E Wieckowski, S Bernstein, VE Herrin, MA Shams, SM Steinberg, M Merino, W Gooding, C Visus, AB DeLeo, JK Wolf, JG Bell, JA Berzofsky, TL Whiteside, SN Khleif	Cancer Immunology, Immunotherapy	2011
Effect of Oxygen Levels on the Physiology of Dendritic Cells: Implications for Adoptive Cell Therapy D Futalan, CT Huang, IG Schmidt-Wolf, M Larsson, D Messmer	Molecular Medicine	2011
Novel Immunotherapeutic Strategies of Gastric Cancer Treatment A Amedei, M Benagiano, C Bella, E Niccolai, MM D'Elios	Journal of Biomedicine and Biotechnology	2011
Disruption of the SapM locus in Mycobacterium bovis BCG improves its protective efficacy as a vaccine against M. tuberculosis N Festjens, P Bogaert, A Batni, E Houthuys, E Plets, D Vanderschaeghe, B Laukens, B Asselbergh, E Parthoens, RD Rycke, MA Willart, P Jacques, D Elewaut, P Brouckaert, BN Lambrecht, K Huygen, N Callewaert	EMBO Molecular Medicine	2011
Immunological and Clinical Effects of Vaccines Targeting p53-Overexpressing Malignancies R Vermeij, N Leffers, SH van der Burg, CJ Melief, T Daemen, HW Nijman	Journal of Biomedicine and Biotechnology	2011
Cancer-Immune Equilibrium: Questions Unanswered A Bhatia, Y Kumar	Cancer Microenvironment	2011
Specific microtubule-depolymerizing agents augment efficacy of dendritic cell-based cancer vaccines CC Wen, HM Chen, SS Chen, LT Huang, WT Chang, WC Wei, LC Chou, P Arulselvan, JB Wu, SC Kuo, NS Yang	Journal of Biomedical Science	2011
Carthamus Tinctorius Enhances the Antitumor Activity of Dendritic Cell Vaccines via Polarization toward Th1 Cytokines and Increase of Cytotoxic T Lymphocytes JM Chang, LM Hung, YJ Chyan, CM Cheng, RY Wu	Evidence-based complementary and alternative medicine : eCAM	2011
Tolerogenic dendritic cells and their potential applications J Hu, Y Wan	Immunology	2011
Biomaterial-Based Vaccine Induces Regression of Established Intracranial Glioma in Rats OA Ali, E Doherty, WJ Bell, T Fradet, J Hudak, MT Laliberte, DJ Mooney, DF Emerich	Pharmaceutical Research	2011
In vivo modulation of dendritic cells by engineered materials: Towards new cancer vaccines J Kim, DJ Mooney	Nano Today	2011
Engineering Dendritic Cells to Enhance Cancer Immunotherapy JE Boudreau, A Bonehill, K Thielemans, Y Wan	Molecular Therapy	2011
Generation of immunogenic and tolerogenic clinical-grade dendritic cells T Kalantari, E Kamali-Sarvestani, B Ciric, MH Karimi, M Kalantari, A Faridar, H Xu, A Rostami	Immunologic Research	2011
Dendritic cell vaccines in cancer immunotherapy: from biology to translational medicine H Xu, X Cao	Frontiers of Medicine	2011
Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials J Fučíková, D Rožková, H Ulčová, V Budinský, K Sochorová, K Pokorná, J Bartůňková, R Špíšek	Journal of Translational Medicine	2011
CD40-Activated B Cell Cancer Vaccine Improves Second Clinical Remission and Survival in Privately Owned Dogs with Non-Hodgkin's Lymphoma KU Sorenmo, E Krick, CM Coughlin, B Overley, TP Gregor, RH Vonderheide, NJ Mason	PloS one	2011
Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model K Durgan, M Ali, P Warner, YE Latchman	Cancer Immunology, Immunotherapy	2011
HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy IG Zizzari, F Veglia, F Taurino, H Rahimi, E Quaglino, F Belleudi, F Riccardo, M Antonilli, C Napoletano, F Bellati, P Benedetti-Panici, MR Torrisi, L Frati, M Nuti, A Rughetti	Journal of Molecular Medicine	2011
TLR4 Engagement during TLR3-Induced Proinflammatory Signaling in Dendritic Cells Promotes IL-10–Mediated Suppression of Antitumor Immunity D Bogunovic, O Manches, E Godefroy, A Yewdall, A Gallois, AM Salazar, I Marie, DE Levy, N Bhardwaj	Cancer research	2011
A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy. Cho NH, Cheong TC, Min JH, Wu JH, Lee SJ, Kim D, Yang JS, Kim S, Kim YK, Seong SY	Nature Nanotechnology	2011
Prolonged antigen storage endows merocytic DC with enhanced capacity to prime anti-tumor responses in tumor-bearing mice RA Reboulet, CM Hennies, Z Garcia, S Nierkens, EM Janssen	Journal of immunology (Baltimore, Md. : 1950)	2010
Quality assessment of cellular therapies: the emerging role of molecular assays DF Stroncek, P Jin, J Ren, J Feng, L Castiello, S Civini, E Wang, FM Marincola, M Sabatino	The Korean Journal of Hematology	2010
Whole tumor antigen vaccines CL Chiang, F Benencia, G Coukos	Seminars in Immunology	2010
Dendritic cell-based immunotherapy for prostate cancer H Jähnisch, S Füssel, A Kiessling, R Wehner, S Zastrow, M Bachmann, EP Rieber, MP Wirth, M Schmitz	Clinical & developmental immunology	2010
CCL3 and CCL20-recruited dendritic cells modified by melanoma antigen gene-1 induce anti-tumor immunity against gastric cancer ex vivo and in vivo S He, L Wang, Y Wu, D Li, Y Zhang	Journal of Experimental & Clinical Cancer Research	2010
Cancer vaccine by fusions of dendritic and cancer cells S Koido, E Hara, S Homma, Y Namiki, T Ohkusa, J Gong, H Tajiri	Clinical & developmental immunology	2010
1-MT enhances potency of tumor cell lysate-pulsed dendritic cells against pancreatic adenocarcinoma by downregulating the percentage of tregs Y Li, J Xu, H Zou, C Wang	Journal of Huazhong University of Science and Technology [Medical Sciences]	2010
Viral Vaccines and CTL Response SN Woolard, U Kumaraguru	Journal of Biomedicine and Biotechnology	2010
Novel cancer vaccine based on genes of Salmonella pathogenicity island 2 G Xiong, MI Husseiny, L Song, A Erdreich-Epstein, GM Shackleford, RC Seeger, D Jäckel, M Hensel, LS Metelitsa	International Journal of Cancer	2010
Prostate cancer as a model for tumour immunotherapy CG Drake	Nature Reviews Immunology	2010
Gene Carriers and Transfection Systems Used in the Recombination of Dendritic Cells for Effective Cancer Immunotherapy YZ Chen, XL Yao, Y Tabata, S Nakagawa, JQ Gao	Clinical and Developmental Immunology	2010
Overview of Cellular Immunotherapy for Patients with Glioblastoma E Vauleon, T Avril, B Collet, J Mosser, V Quillien	Clinical and Developmental Immunology	2010
Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination Y Wen, H Wang, H Wu, F Yang, RA Tripp, RJ Hogan, ZF Fu	Journal of virology	2010
Three-day dendritic cells for vaccine development: antigen uptake, processing and presentation M Bürdek, S Spranger, S Wilde, B Frankenberger, DJ Schendel, C Geiger	Journal of Translational Medicine	2010
FRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapy L Fiammenghi, V Ancarani, T Rosales, JR Knutson, M Petrini, AM Granato, E Pancisi, L Ridolfi, R Ridolfi, A Riccobon, P Neyroz	Journal of Translational Medicine	2010
The establishment of dendritic cell-tumor fusion vaccines for hormone refractory prostate cancer cell TB Kim, HK Park, JH Chang, IH Choi, KH Kim, SJ Yoon, MS Lee, H Jung, CS Kim	Korean Journal of Urology	2010
Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies P Jin, TH Han, J Ren, S Saunders, E Wang, FM Marincola, DF Stroncek	Journal of Translational Medicine	2010
Well-defined block copolymers for gene delivery to dendritic cells: probing the effect of polycation chain-length R Tang, RN Palumbo, L Nagarajan, E Krogstad, C Wang	Journal of Controlled Release	2010
In vivo imaging of immune cell trafficking in cancer L Ottobrini, C Martelli, DL Trabattoni, M Clerici, G Lucignani	European Journal of Nuclear Medicine and Molecular Imaging	2010
Mitochondria-centric activation induced cell death of cytolytic T lymphocytes and its implications for cancer immunotherapy A Chhabra	Vaccine	2010
Characterization of transglutaminase type II role in dendritic cell differentiation and function I Matic, A Sacchi, A Rinaldi, G Melino, C Khosla, L Falasca, M Piacentini	Journal of leukocyte biology	2010
Significant anti-tumour activity of adoptively transferred T cells elicited by intratumoral dendritic cell vaccine injection through enhancing the ratio of CD8+ T cell/regulatory T cells in tumour S Song, K Zhang, H You, J Wang, Z Wang, C Yan, F Liu	Clinical & Experimental Immunology	2010
Dendritic cells transfected with Her2 antigen-encoding RNA replicons cross-prime CD8 T cells and protect mice against tumor challenge B Edlich, LJ Hogdal, B Rehermann, SE Behrens	Vaccine	2010
Survival in rectal cancer is predicted by T cell infiltration of tumour-associated lymphoid nodules TP McMullen, R Lai, L Dabbagh, TM Wallace, CJ de Gara	Clinical & Experimental Immunology	2010
Dendritic Cells Loaded with Tumor B Cells Elicit Broad Immunity against Murine Gammaherpesvirus 68 but Fail To Prevent Long-Term Latency J Weslow-Schmidt, F Ye, SS Cush, KA Stuller, MA Blackman, E Flaño	Journal of virology	2010
In vivo trafficking and immunostimulatory potential of an intranasally-administered primary dendritic cell-based vaccine P Vilekar, V Awasthi, P Lagisetty, C King, N Shankar, S Awasthi	BMC Immunology	2010
Comparative Analysis of Cytotoxic T Lymphocyte Response Induced by Dendritic Cells Loaded with Hepatocellular Carcinoma -Derived RNA or Cell Lysate Pan K, Zhao JJ, Wang H, Li JJ, Liang XT, Sun JC, Chen YB, Ma HQ, Liu Q, Xia JC	International journal of biological sciences	2010
Cancer vaccine development: Designing tumor cells for greater immunogenicity Bozeman EN, Shashidharamurthy R, Paulos SA, Palaniappan R, D\u2019Souza M, Selvaraj P		2010
Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism LA Norian, PC Rodriguez, LA O'Mara, J Zabaleta, AC Ochoa, M Cella, PM Allen	Cancer research	2009
Pulmonary surfactant: an immunological perspective ZC Chroneos, Z Sever-Chroneos, VL Shepherd	Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology	2009
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments OM Grauer, P Wesseling, GJ Adema	Brain Pathology	2009
In situ regulation of DC subsets and T cells mediates tumor regression in mice OA Ali, D Emerich, G Dranoff, DJ Mooney	Science Translational Medicine	2009
The Tat-conjugated N-terminal region of mucin antigen 1 (MUC1) induces protective immunity against MUC1-expressing tumours H Yang, NH Cho, SY Seong	Clinical & Experimental Immunology	2009
Protective anti-tumour immune responses by murine dendritic cells pulsed with recombinant Tat-carcinoembryonic antigen derived from Escherichia coli MY Bae, NH Cho, SY Seong	Clinical & Experimental Immunology	2009
Immune tolerance induction by integrating innate and adaptive immune regulators J Suzuki, C Ricordi, Z Chen	Cell transplantation	2009
Engulfing tumors with synthetic extracellular matrices for cancer immunotherapy Y Hori, PJ Stern, RO Hynes, DJ Irvine	Biomaterials	2009
Modular injectable matrices based on alginate solution/microsphere mixtures that gel in situ and co-deliver immunomodulatory factors Y Hori, AM Winans, DJ Irvine	Acta Biomaterialia	2009
Behavior of immune players in the tumor microenvironment MJ Pittet	Current Opinion in Oncology	2009
Abrogation of Local Cancer Recurrence After Radiofrequency Ablation by Dendritic Cell-based Hyperthermic Tumor Vaccine Q Liu, B Zhai, W Yang, LX Yu, W Dong, YQ He, L Chen, L Tang, Y Lin, DD Huang, HP Wu, MC Wu, HX Yan, HY Wang	Molecular Therapy	2009
Identification of a 17beta-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide RC Hendrickson, VR Cicinnati, A Albers, G Dworacki, A Gambotto, O Pagliano, T Tüting, JI Mayordomo, C Visus, E Appella, J Shabanowitz, DF Hunt, AB DeLeo	Cancer Immunology, Immunotherapy	2009
Recombinant vesicular stomatitis virus transduction of dendritic cells enhances their ability to prime innate and adaptive antitumor immunity JE Boudreau, BW Bridle, KB Stephenson, KM Jenkins, J Brunellière, JL Bramson, BD Lichty, Y Wan	Molecular Therapy	2009
Production of antibodies against multipass membrane proteins expressed in human tumor cells using dendritic cell immunization T Tamura, J Chiba	Journal of biomedicine & biotechnology	2009
Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells RJ Creusot, SS Yaghoubi, P Chang, J Chia, CH Contag, SS Gambhir, CG Fathman	Blood	2009
Evaluation of 3 clinical dendritic cell maturation protocols containing lipopolysaccharide and interferon-gamma TH Han, P Jin, J Ren, S Slezak, FM Marincola, DF Stroncek	Journal of immunotherapy (Hagerstown, Md. : 1997)	2009
Generation in vivo of peptide-specific cytotoxic T cells and presence of regulatory T cells during vaccination with hTERT (class I and II) peptide-pulsed DCs MM Aloysius, AJ Kechnie, RA Robins, C Verma, JM Eremin, F Farzaneh, NA Habib, J Bhalla, NR Hardwick, S Satthaporn, T Sreenivasan, M El-Sheemy, O Eremin	Journal of Translational Medicine	2009
In vivo dendritic cell tracking using fluorescence lifetime imaging and near-infrared-emissive polymersomes NA Christian, F Benencia, MC Milone, G Li, PR Frail, MJ Therien, G Coukos, DA Hammer	Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging	2009
Infection-mimicking materials to program dendritic cells in situ OA Ali, N Huebsch, L Cao, G Dranoff, DJ Mooney	Nature Materials	2009
Antigen-Specific T-Cell Response from Dendritic Cell Vaccination Using Cancer Stem-Like Cell-Associated Antigens Q Xu, G Liu, X Yuan, M Xu, H Wang, J Ji, B Konda, KL Black, JS Yu	Stem Cells	2009
Increased extracellular pressure provides a novel adjuvant stimulus for enhancement of conventional dendritic cell maturation strategies DH Craig, H Shiratsuchi, MD Basson	Biochemical and Biophysical Research Communications	2009
Effect of ex vivo culture duration on phenotype and cytokine production by mature dendritic cells derived from peripheral blood monocytes A Tawab, Y Fan, EJ Read, RJ Kurlander	Transfusion	2009
Dendritic Cells as Danger-Recognizing Biosensors M Gi, W Im, S Hong	Sensors (Basel, Switzerland)	2009
Recognition of live phosphatidylserine-labeled tumor cells by dendritic cells: a novel approach to immunotherapy of skin cancer MR Shurin, AI Potapovich, YY Tyurina, IL Tourkova, GV Shurin, VE Kagan	Cancer research	2009
Cytosolic Delivery Mediated via Electrostatic Surface Binding of Protein, Virus, or siRNA Cargos to pH-Responsive Core−Shell Gel Particles Y Hu, PU Atukorale, JJ Lu, JJ Moon, SH Um, EC Cho, Y Wang, J Chen, DJ Irvine	Biomacromolecules	2009
Increases in serum TARC/CCL17 levels are associated with progression-free survival in advanced melanoma patients in response to dendritic cell-based immunotherapy. Cornforth AN, Lee GJ, Fowler AW, Carbonell DJ, Dillman RO	Journal of Clinical Immunology	2009
Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo. Wu YG, Wu GZ, Wang L, Zhang YY, Li Z, Li DC	Medical Oncology	2009
Tumor endothelial marker 8 expression levels in dendritic cell-based cancer vaccines are related to clinical outcome Venanzi FM, Petrini M, Fiammenghi L, Bolli E, Granato AM, Ridolfi L, Gabrielli F, Barucca A, Concetti A, Ridolfi R, Riccobon A	Cancer Immunology, Immunotherapy	2009
An effective vaccine against colon cancer in mice: use of recombinant adenovirus interleukin-12 transduced dendritic cells XZ He, L Wang, YY Zhang	World journal of gastroenterology : WJG	2008
Therapeutic dendritic cell vaccine preparation using tumor RNA transfection: a promising approach for the treatment of prostate cancer JM Sousa-Canavez, FC Canavez, KR Leite, LH Camara-Lopes	Genetic vaccines and therapy	2008
Induction of antigen-specific cytotoxic T lymphocytes by using monocyte-derived DCs transfected with in vitro-transcribed WT1 or SART1 mRNA M Narita, N Tochiki, A Saitoh, N Watanabe, M Kaji, N Satoh, A Yamahira, T Nakamura, M Masuko, T Furukawa, K Toba, I Fuse, Y Aizawa, M Takahashi	Medical Oncology	2008
High-Level Antigen Expression and Sustained Antigen Presentation in Dendritic Cells Nucleofected with Wild-Type Viral mRNA but Not DNA NM Melhem, SM Gleason, XD Liu, SM Barratt-Boyes	Clinical and vaccine immunology : CVI	2008
Prevention of Both Direct and Cross-Priming of Antitumor CD8 + T-Cell Responses following Overproduction of Prostaglandin E 2 by Tumor Cells In vivo M Ahmadi, DC Emery, DJ Morgan	Cancer research	2008
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients FS Hodi, M Butler, DA Oble, MV Seiden, FG Haluska, A Kruse, S Macrae, M Nelson, C Canning, I Lowy, A Korman, D Lautz, S Russell, MT Jaklitsch, N Ramaiya, TC Chen, D Neuberg, JP Allison, MC Mihm, G Dranoff	Proceedings of the National Academy of Sciences	2008
Differentiation of two types of mobilized peripheral blood stem cells by microRNA and cDNA expression analysis P Jin, E Wang, J Ren, R Childs, JW Shin, H Khuu, FM Marincola, DF Stroncek	Journal of Translational Medicine	2008
Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction C Fonseca, R Soiffer, V Ho, M Vanneman, M Jinushi, J Ritz, D Neuberg, R Stone, D DeAngelo, G Dranoff	Blood	2008
Ex vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: critical role of IFN-alpha S Satthaporn, MM Aloysius, RA Robins, C Verma, S Chuthapisith, AJ McKechnie, M El-Sheemy, W Vassanasiri, D Valerio, D Clark, JA Jibril, O Eremin	BMC Immunology	2008
Bone marrow-derived dendritic cells pulsed with tumor lysates induce anti-tumor immunity against gastric cancer ex vivo YL Li, YG Wu, YQ Wang, Z Li, RC Wang, L Wang, YY Zhang	World journal of gastroenterology : WJG	2008
Dendritic cells pulsed with keyhole limpet hemocyanin and cryopreserved maintain anti-tumor activity in a murine melanoma model S Teitz-Tennenbaum, Q Li, MA Davis, AE Chang	Clinical Immunology	2008
Targeting of antigens to B cells augments antigen-specific T-cell responses and breaks immune tolerance to tumor-associated antigen MUC1 C Ding, L Wang, J Marroquin, J Yan	Blood	2008
Whole tumor antigen vaccination using dendritic cells: comparison of RNA electroporation and pulsing with UV-irradiated tumor cells F Benencia, MC Courrèges, G Coukos	Journal of Translational Medicine	2008
Increased TLR responses in dendritic cells lacking the ITAM-containing adapters DAP12 and FcRgamma CL Chu, YL Yu, KY Shen, CA Lowell, LL Lanier, JA Hamerman	European Journal of Immunology	2008
Culture of myeloid dendritic cells from bone marrow precursors J Boudreau, S Koshy, D Cummings, Y Wan	Journal of visualized experiments : JoVE	2008
Type 2 Bias of T Cells Expanded from the Blood of Melanoma Patients Switched to Type 1 by IL-12p70 mRNA–Transfected Dendritic Cells K Minkis, DG Kavanagh, G Alter, D Bogunovic, D O'Neill, S Adams, A Pavlick, BD Walker, MA Brockman, RT Gandhi, N Bhardwaj	Cancer research	2008
Dual Signaling of MyD88 and TRIF are Critical for Maximal TLR4-Induced Dendritic Cell Maturation Shen H, Tesar BM, Walker WE, Goldstein DR	Journal of immunology (Baltimore, Md. : 1950)	2008
Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters Engell-Noerregaard L, Hansen TH, Andersen MH, thor Straten P, Svane IM	Cancer Immunology, Immunotherapy	2008
Series overview: Harnessing the immune system to treat cancer Nina Bhardwaj	Journal of Clinical Investigation	2007
Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens LJ Young, NS Wilson, P Schnorrer, A Mount, RJ Lundie, NL la Gruta, BS Crabb, GT Belz, WR Heath, JA Villadangos	Proceedings of the National Academy of Sciences	2007
Activation of cytotoxic T lymphocytes against CML28-bearing tumors by dendritic cells transduced with a recombinant adeno-associated virus encoding the CML28 gene LH Xie, FW Sin, SC Cheng, YK Cheung, KT Chan, Y Xie, Y Xie	Cancer Immunology, Immunotherapy	2007

Advertisement